HLA-G and allergic rhinitis: In their research, Ciprandi et al. found that sublingual immunotherapy (SLIT) in allergic rhinitis is able to lower serum sHLA-G levels in pollen-allergic patients, which may suggest clinical implications as a biomarker of SLIT response [146,147].